From: Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals
Focus group | Region | Participants; N | % female | Age range | Work experience* |
---|---|---|---|---|---|
G1 | Aragon | 7 | 71% | 43-62 | 25.4 (6.9) |
G2 | Aragon | 5 | 40% | 40-50 | 22.0 (8.0) |
G3 | Aragon | 8 | 38% | 43-58 | 25.0 (5.9) |
G4 | Aragon | 9 | 78% | 28-56 | 13.6 (10.6) |
G5 | Balearic Islands | 14 | 57% | 30-61 | 17.7 (10.4) |
G6 | Balearic Islands | 7 | 43% | 35-53 | 21.6 (6.5) |
G7 | Balearic Islands | 8 | 63% | 39-62 | 23.6 (6.4) |
G8 | Catalonia | 9 | 78% | 28-47 | 6.8 (3.6) |
G9 | Catalonia | 6 | 50% | 28-55 | 15.5 (10.8) |
G10 | Catalonia | 7 | 57% | 28-50 | 6.7 (4.2) |
G11 | Catalonia | 2 | 100% | 34-43 | 13 (6.0) |